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ttp://dx.doi.org/10.1016/j.ajpath.2014.03.017Our research group recently demonstrated that pericytes are major sources of the secreted glycoprotein
and integrin ligand lactadherin (MFG-E8) in B16 melanoma tumors, and that MFG-E8 promotes angio-
genesis via enhanced PDGFePDGFRb signaling mediated by integrinegrowth factor receptor crosstalk.
However, sources of MFG-E8 and its possible roles in skin physiology are not well characterized. The
objective of this study was to characterize the involvement of MFG-E8 in skin wound healing. In the
dermis of normal murine and human skin, accumulations of MFG-E8 were found around CD31þ blood
vessels, and MFG-E8 colocalized with PDGFRbþ, aSMAþ, and NG2þ pericytes. MFG-E8 protein and mRNA
levels were elevated in the dermis during full-thickness wound healing in mice. MFG-E8 was diffusely
present in granulation tissue and was localized around blood vessels. Wound healing was delayed in MFG-
E8 knockout mice, compared with the wild type, and myoﬁbroblast and vessel numbers in wound areas
were signiﬁcantly reduced in knockout mice. Inhibition of MFG-E8 production with siRNA attenuated the
formation of capillary-like structures in vitro. Expression of MFG-E8 in ﬁbrous human granulation tissue
with scant blood vessels was less than that in granulation tissue with many blood vessels. These ﬁndings
suggest that MFG-E8 promotes cutaneous wound healing by enhancing angiogenesis. (Am J Pathol 2014,
184: 1981e1990; http://dx.doi.org/10.1016/j.ajpath.2014.03.017)Supported in part by a grant from Adaptable and Seamless Technology
Transfer Program of the Japan Science and TechnologyAgency, a grant from
the Uehara Memorial Foundation (S.M.), and the Intramural Program of the
NIH, Center for Cancer Research, National Cancer Institute (M.C.U.).
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Disclosures: None declared.Wound healing is a dynamic process involving angiogenesis,
production of soluble mediators and extracellular matrix, and
migration of various types of cells, including keratinocytes,
ﬁbroblasts, macrophages, and leukocytes. Dysregulation of
this interactive process may result in delayed wound healing,
as is seen in chronic skin ulcers or scarring. Wound healing
has three temporally overlapping phases: inﬂammation, tis-
sue formation, and remodeling.1,2 The inﬂammation phase
occurs immediately after wounding. It is characterized by
hypoxia with ﬁbrin clot formation, as well as recruitment of
neutrophils and platelets. Tissue formation occurs 2 to 10
days later and is characterized by epithelialization, formation
of granulation tissue and new blood vessels, and accumula-
tion of macrophages and ﬁbroblasts. Activated macrophages
release growth factors, such as vascular endothelial growth
factor (VEGF) and platelet-derived growth factor (PDGF),
and initiate angiogenesis. PDGF receptor b (PDGFRb)
signaling is essential for angiogenesis and for recruitment,
proliferation, and normal function of ﬁbroblasts and pericytesstigative Pathology.
.during the tissue-formation phase.3 Blockade of VEGF re-
ceptor signaling and PDGFRb signaling inhibits angiogen-
esis and results in delayed wound healing,3,4 indicating that
angiogenesis is critical for normal wound healing.
The secreted glycoprotein lactadherin was initially iden-
tiﬁed as a component of milk fat globules and is here referred
to as milk fat globule-EGF factor 8 (MFG-E8); other names
in the literature include secreted protein containing epidermal
growth factor (EGF) repeats and discoidin/F5/8 domains 1,
or SED1. MFG-E8 comprises two N-terminal EGF-like do-
mains, and two C-terminal discoidin-like domains (C1 and
C2) share homology with blood coagulation factors V and
VIII.5e9 One EGF-like domain (E2) contains an RGD
Uchiyama et alconsensus integrin-binding motif, and MFG-E8 binds to
integrin avb3/5.7e11 The C-terminal domains of MFG-E8
can bind to negatively charged and oxidized phospho-
lipids,12,13 facilitating opsonization of apoptotic cells for
uptake by phagocytes.10,14 This process has been reported to
contribute to autoimmunity, mastitis, sepsis, atherosclerosis,
and Alzheimer disease.15e19 Interactions of MFG-E8 with
CD51 (integrin av) have also been implicated in regulation of
angiogenesis and mammary gland branching,11,20 and in-
teractions mediated via the C1 domain are thought to be
important for spermeegg binding and collagen turnover.21,22
Our research group has previously demonstrated that MFG-
E8 enhances angiogenesis in tumors and in oxygen-induced
retinopathy in mice.23 We determined that pericytes and/or
pericyte precursors are important sources of MFG-E8 in vivo,
that MFG-E8 enhances angiogenesis via actions on pericytes as
well as endothelial cells (ECs), and that MFG-E8 can be effec-
tively targeted with therapeutic beneﬁt.23 In murine melanomas
and in retinas of mice with oxygen-induced retinopathy, MFG-
E8colocalizedwithpericytes rather thanwithECs, andpericytes
puriﬁed from tumors contained large amounts of MFG-E8
mRNA. Tumor- and retinopathy-associated angiogenesis was
diminished in MFG-E8 knockout (KO) mice, and pericyte
coverage of neovessels was also reduced. Inhibition ofMFG-E8
production by pericyte/pericyte precursor-like 10T1/2 cells
using siRNAs, or inhibition of MFG-E8 action with some
antieMFG-E8 antibodies, attenuated PDGF-BBeinduced
10T1/2 cell migration, but did not affect proliferation or differ-
entiation.23We have also determined thatMFG-E8 produced by
10T1/2 cells associated with integrin av and PDGFRb on cell
surfaces after PDGF-BB treatment, altered the distribution of
PDGFRb within cells and delayed PDGF-BBestimulated
degradationofPDGFRb, thereby enhancingPDGFRb signaling
mediated by integrinegrowth factor receptor crosstalk.24
In a study of MFG-E8, epithelial tissues, and wound
healing, Bu et al25 found that MFG-E8 promotes the migra-
tion of intestinal epithelial cells via a PKCε-dependent
mechanism engaged by binding of MFG-E8 to phosphati-
dylserine. Their ﬁndings indicate that MFG-E8 is involved in
the maintenance of intestinal epithelial homeostasis and the
promotion of mucosal healing. The possible role of MFG-E8
in cutaneous wound healing has not been studied previously.
In the present study, we analyzed skin wound healing using
MFG-E8 wild-type (WT) and KO mice. We demonstrate that
MFG-E8 production was increased and that MFG-E8 accu-
mulated in granulation tissue during wound healing, and that
wound healing in MFG-E8 KO mice was delayed. We relate
delayed wound healing to diminished angiogenesis and
myoﬁbroblast inﬁltration in wounds in MFG-E8 KO mice.
Materials and Methods
Mice
MFG-E8 KO mice were generated, characterized, and geno-
typed as described previously.23,26 Heterozygous founders were1982speed-backcrossed to C57BL/6 or BALB/c mice to generate
animals with appropriate and uniform genetic backgrounds
using the Speed Congenics Services of the Laboratory Animal
Sciences Program at the National Cancer InstituteeFrederick
Center for Cancer Research (NIH, Bethesda, MD). MFG-
E8edeﬁcient mice were generated by interbreeding homozy-
gous animals carrying the targeted MFG-E8 allele. Control
animals were purchased from Japan SLC (Hamamatsu, Japan).
Eight- to twelve-week-old C57BL/6 or BALB/c mice were
used for all experiments. Mice were bred and maintained at the
Institute of Experimental Animal Research of Gunma Univer-
sity Graduate School ofMedicine under speciﬁc pathogenefree
conditions. Mice were handled in accordance with the animal
care guidelines of Gunma University.
Human Skin and Granulation Tissues
Normal human skin was obtained from the forearm of
healthy volunteers. For the examination of human granula-
tion tissue, normal and ﬁbrous granulation tissue specimens
were obtained from patients with decubitus ulcers. Ethics
approval was granted by the local research ethics commit-
tee. All patients and volunteers provided written informed
consent before participation. This study was conducted ac-
cording to the Declaration of Helsinki principles.
Antibodies
The following antibodies were used: rat anti-mouse CD31
monoclonal antibody (mAb) (MEC13.3; BD Biosciences, San
Jose, CA), rabbit anti-mouse NG2 polyclonal antibody (pAb)
(EMDMillipore,Billerica,MA), rat anti-mousePDGFRbmAb
(eBioscience, San Diego, CA), rat anti-mouse CD68 mAb
(Bio-Rad Laboratories, Hercules, CA), mouse antiea-smooth
muscle actin (SMA) mAb (Sigma-Aldrich, St. Louis, MO),
rabbit anti-humanCD31 pAb (Abcam, Cambridge, UK), rabbit
anti-human aSMA pAb (Abcam), and mouse anti-human
MFG-E8 pAb (R&D Systems, Minneapolis, MN). Secondary
antibodies conjugatedwithAlexa Fluor 488 orAlexa Fluor 568
were obtained from Life Technologies (Carlsbad, CA). Rabbit
anti-mouse MFG-E8 pAb was generated and characterized in
our laboratory as described previously.23,24
Immunoﬂuorescence Staining
For whole-mount staining of ear skin, mouse ears were
excised and split into dorsal and ventral halves, and cartilage
and fat were removed. Skin sheets (including both dermis and
epidermis) were ﬁxed in cold acetoneemethanolewater
(2:2:1) for 10 minutes or in 4% paraformaldehyde for 30
minutes. After blocking with 3% nonfat dry milkePBS
supplemented with 5% normal goat serum for 1 hour at room
temperature, sections were stained with the antibody of in-
terest, followed by the secondary antibody conjugated with
Alexa Fluor 488 or Alexa Fluor 568. Immunoﬂuorescence
staining of frozen sections and analysis was performed asajp.amjpathol.org - The American Journal of Pathology
Figure 1 MFG-E8 localizes in close proximity to pericytes/vascular smooth
muscle cells in the dermis of mouse and human skin. A: Localization of MFG-E8
in relationship to ECs (CD31þ) or pericytes (aSMAþ) in C57BL/6mouse dermis.
B: Localization of MFG-E8 in relationship to ECs (CD31þ) in the dermis of whole
mount of C57BL/6 mouse ear skin. C: Localization of MFG-E8 in relationship to
pericytes (PDGFRbþ) (arrows) in the dermis of whole mount of ear skin from
MFG-E8 WT and KO C57BL/6 mice. D: Localization of MFG-E8 in relationship to
ECs (CD31þ) and pericytes (NG2þ) in human dermis in frozen skin sections.
Scale barZ 20 mm.
MFG-E8 and Cutaneous Wound Healingdescribed previously.23,24 Frozen sections (4 mm thick) pre-
pared from murine and human skin were ﬁxed in 4% para-
formaldehyde in PBS for 30 minutes. After blocking with 3%
nonfat dry milkePBS supplemented with either 5% normal
donkey serum or 5% normal goat serum for 1 hour at room
temperature, sections were stained with the antibody of in-
terest followed by the secondary antibody conjugated with
Alexa Fluor 488 or Alexa Fluor 568. Sections were coun-
terstained with to visualize nuclei and were mounted in
ProLong Gold antifade reagent (Life Technologies).
Wound Healing Model and Analysis
Full-thickness wounds were made and examined as described
previously.27,28 In brief, mice were anesthetized, shaved, and
cleaned with 70% ethanol. Two 5-mm full-thickness exci-
sional dorsal skin wounds were made on each side of the
midline with a sterile disposable biopsy punch (Kai Industries,
Gifu, Japan).Wounds were covered by ﬁlm dressings (Perme-
roll; Nitto Denko, Osaka, Japan). Wound sites were digitally
photographed at various time points after wounding, and
wound areas were measured on the images using ImageJ
software version 1.46r (NIH, Bethesda, MD). Changes in
wound area are expressed as percentage of initial wound area.
To assess effects of recombinant MFG-E8 (rMFG-E8) on
wound healing in KOmice, 400 ng rMFG-E8 (R&D Systems,
Minneapolis,MN)per 30mLPBSor the same concentrations of
bovine serum albumin was injected into the dermis around the
wound every day after wounding until the closure of wound.
RT-qPCR
Total RNA was isolated using RNeasy mini kits (Qiagen,
Valencia, CA) and was subjected to reverse transcription with
use of a SuperScript III ﬁrst-strand synthesis system (Life
Technologies) according to the manufacturer’s instructions.
Real-time quantitative reverse transcription PCR (RT-qPCR)
was performed using a TaqMan system (Life Technologies)
with ABI 7300 real-time PCR instrumentation (Life Tech-
nologies) according to the manufacturer’s instructions. Taq-
Man probes and primers for MFG-E8, CD31, aSMA, CD68,
and GAPDH were purchased from Life Technologies. As an
internal control, levels of GAPDH were quantiﬁed in parallel
with target genes. Normalization and fold changes were
calculated using the comparative CT method.
MFG-E8 Knockdown Experiments and Capillary-Like
Structure Formation Assay
Mouse C3H/10T1/2 cells were kindly provided by Dr. T. Iso
(Department of Medicine and Biological Science, Gunma
University, Maebashi, Japan). Human umbilical vein endo-
thelial cells (HUVECs) were purchased from ATCC (Man-
assas, VA). 10T1/2 cells were maintained in BME medium
(Life Technologies) supplemented with 10% heat-inactivated
fetal bovine serum, 2 mmol/L L-glutamine, 100 U/mLThe American Journal of Pathology - ajp.amjpathol.orgpenicillin, 100 mg/mL streptomycin and were used before
passage 10. HUVECs were maintained in EBM-2 basal
medium (Lonza, Basel, Switzerland; Walkersville, MD)
supplemented with EGM-2 SingleQuots kit with growth1983
Uchiyama et alfactors, cytokines, and supplements (Lonza). siRNAs spe-
ciﬁc for mouse and human MFG-E8 mRNA were designed
with Qiagen. The targeting sequences were as follows:
mouse MFG-E8 siRNA, 50-AAGCGGTGGAGACAAGG-
AGTT-30); human MFG-E8 siRNA, 50-TACAGCCT-
TAATGGACACGAA-30. siRNAs and AllStars negative1984control siRNAwere purchased fromQiagen. To inhibit MFG-
E8 production, 5 105 10T1/2 cells and HUVECs per 60-mm
plate were transfected with 10 nmol/L siRNA using HiPerFect
transfection reagent (Qiagen).
The capillary-like structure formation assay was per-
formed as described previously.29,30 At 24 hours after siRNA
transfection, 2.5  104 HUVECs and/or 2.5  104 10T1/2
cells were cultured in solidiﬁed Matrigel (200 mL/well in
24-well plates) (BD Biosciences) and were incubated at
37C. After 3 hours, six random ﬁelds were chosen in each
well, and the total length of capillary-like structures was
quantiﬁed using ImageJ software. To examine the effects of
MFG-E8 siRNA, MFG-E8 mRNA levels were assessed by
RT-qPCR immediately after the tube formation assay.
Human and mouse MFG-E8 protein secreted into the me-
dium during a 24-hour incubation were assessed with the use
of ELISA kits (R&D Systems).
Statistical Analysis
P values were calculated using Student’s t-test (two-sided)
or by analysis of one-way analysis of variance followed by
Bonferroni’s post hoc test. Data are expressed as means 
SEM, and numbers of experiments (n) are indicated.
Results
Localization of MFG-E8 in Close Proximity to Pericytes/
Vascular Smooth Muscle Cells in Dermis of Murine and
Human Skin
To localize MFG-E8 in normal murine skin, immunoﬂuo-
rescence staining of vertical sections of back skin and whole
mounts (epidermis and dermis) of normal C57BL/6 mouse
ear skin was performed. Accumulations of MFG-E8 were
found around CD31þ ECs in the dermis (Figure 1, A and B,
and Supplemental Figure S1). MFG-E8 deposits frequently
occurred in proximity to vascular branch points (Figure 1B).
MFG-E8 also colocalized with a-smooth muscle actin-
positive (aSMAþ) or PDGFRbþ pericytes in the dermis
(Figure 1, A and C and Supplemental Figure S1). MFG-E8
staining was not observed in skin from MFG-E8 KO mice,
conﬁrming the speciﬁcity of our antibody (Figure 1C). TheseFigure 2 MFG-E8 expression is enhanced in the dermis and granulation
tissue and around blood vessels during wound healing in mice. AeC:
Localization and expression of MFG-E8 during skin wound healing in C57BL/6
mice as revealed by immunoﬂuorescence staining at days 4 (A), 7 (B),
and 14 (C) after wounding. Boxed areas in B are shown enlarged in the
corresponding individual images. D: RT-qPCR quantiﬁcation of MFG-E8,
CD31, and aSMA mRNA levels in wound areas at 0, 7, and 14 days after
wounding, expressed relative to mRNA levels at day 0. EeG: Localization of
MFG-E8 in relationship to ECs (CD31þ) (E), pericytes/myoﬁbroblasts
(aSMAþ) (F), and macrophages (CD68þ) (G) in granulation tissue at 7 days
after wounding. Data are expressed as means  SEM, determined in three
independent experiments. **P < 0.01, analysis of variance followed by
Bonferroni’s post hoc test. Scale barZ 20 mm.
ajp.amjpathol.org - The American Journal of Pathology
Figure 3 Skin wound healing is delayed in MFG-
E8 KO mice. A and B: Percent wound area at each
time point relative to the original wound area in
MFG-E8 WT and KO C57BL/6 mice (A) and BALB/c
mice (B). C: Percent wound areas at each time point
relative to the original wound area in MFG-E8 WT
C57BL/6 mice treated with control bovine serum
albumin and in KO C57BL/6 mice treated with
control bovine serum albumin or rMFG-E8. Data are
expressed as means SEM. *P< 0.05, **P< 0.01,
analysis of variance followed by Bonferroni’s post
hoc test; yyP < 0.01, Student’s t-test. n Z 6 (C);
n Z 24 (A, KO); n Z 30 (A, WT); n Z 34 (B) for
each time point and group.
MFG-E8 and Cutaneous Wound Healingresults are consistent with our previous studies identifying
pericytes as important sources of MFG-E8 in melanoma tu-
mors in vivo.23 We also analyzed the distribution of MFG-E8
in normal human skin. Staining of human skin sections
revealed that MFG-E8 staining occurred almost exclusively
in close proximity to CD31þ blood vessels (Figure 1D), and
MFG-E8 colocalized with NG2þ pericytes (Figure 1D).
These results suggest that MFG-E8 localizes in close prox-
imity to pericytes/vascular smooth muscle cells in the dermis
of murine and human skin.Enhancement of MFG-E8 Expression in the Dermis and
Granulation Tissue with Localization Near Blood
Vessels during Wound Healing
We next examined the expression and localization of MFG-
E8 during wound healing in murine skin. At 4 days after
wounding, MFG-E8 staining was increased in granulation
tissue in wound areas, compared with that in surrounding
areas (Figure 2A). Furthermore, at 7 days after wounding,
MFG-E8 staining was signiﬁcantly increased in wound areas
and was distributed diffusely in granulation tissue
(Figure 2B). At 14 days after wounding, MFG-E8 expression
persisted in the dermis of wound areas (Figure 2C).
Expression of MFG-E8 mRNA in wound areas was exam-
ined by RT-qPCR. MFG-E8 mRNA levels at 7 and 14 days
after wounding were three- to fourfold greater than at base-
line (Figure 2D). CD31 and aSMA mRNA expression was
also increased at 7 and 14 days after wounding (Figure 2D).
These results suggest that protein and mRNA levels of MFG-The American Journal of Pathology - ajp.amjpathol.orgE8 in granulation tissue were enhanced during wound heal-
ing, and that expression of EC and pericyte markers was also
increased.
Next, we examined the precise distribution of MFG-E8 in
granulation tissue in relation to ECs, pericytes, and macro-
phages. At 7 days after wounding, MFG-E8 was present
diffusely in granulation tissue, with enhanced accumulation
aroundCD31þ ECs (Figure 2E).MFG-E8 staining overlapped
more extensively with aSMA, suggesting that aSMAþ peri-
cytes or myoﬁbroblasts in granulation tissue may be an
important source of MFG-E8 (Figure 2F). Notably, MFG-E8
did not colocalize with CD68þ macrophages (Figure 2G).
These results indicate that MFG-E8 increases in granulation
tissue and suggest that it might regulate angiogenesis inwound
healing.Delayed Cutaneous Wound Healing in MFG-E8 KO Mice
To assess the role of MFG-E8 in wound healing in vivo, we
compared the kinetics of cutaneous wound healing in MFG-
E8 WT and KO mice on C57BL/6 and BALB/c genetic
backgrounds. In C57BL/6 mice, wound healing was
signiﬁcantly delayed (by approximately 1 day) in MFG-E8
KO mice from 4 to 10 days after wounding, compared with
WT mice (Figure 3A). In BALB/c mice, wound healing was
signiﬁcantly delayed (by approximately 2 days) in MFG-E8
KO mice from 2 to 14 days after wounding, compared with
WT mice (Figure 3B). Furthermore, rMFG-E8 treatment
negated the delay in wound healing in MFG-E8 KO mice
(Figure 3C). These ﬁndings suggest that MFG-E8 positively1985
Figure 4 Blood vessels and myoﬁbroblasts in wound areas are reduced in MFG-E8 KO mice. A: Distribution of ECs (CD31þ) and pericytes (NG2þ) in the
granulation tissue in the wound in MFG-E8 WT and KO C57BL/6 mice at 7 days after wounding. B: Distribution of aSMAþ pericytes or myoﬁbroblasts in the
dermis of wounds in MFG-E8 WT/KO C57BL/6 mice at 7 days after wounding. C: Distribution of CD68þ macrophages in the dermis of wounds in MFG-E8 WT/KO
C57BL/6 mice at 7 days after wounding. AeC: Quantiﬁcation of the CD31þ, NG2þ, aSMAþ, and CD68þ areas in eight random microscopic ﬁelds was performed
using ImageJ software. Positive areas in WT mice were assigned values of 1. The dotted lines indicate the border between the epidermis and the dermis. Data
are expressed as means  SEM. n Z 3 mice per genotype. **P < 0.01, Student’s t-test. Scale bar Z 20 mm.
Uchiyama et alregulates cutaneous wound healing during the tissue-
formation phase, which is characterized by the formation
of granulation tissue and new blood vessels and occurs from
2 to 10 days after wounding.
Reduced Frequencies of Blood Vessels and
Myoﬁbroblasts in Wound Areas in MFG-E8 KO Mice
Because MFG-E8 accumulated around blood vessels in
granulation tissue, we examined the inﬂuence of MFG-E8
on vascularity in wound areas. At 7 days after wounding,
the number of CD31þ ECs and NG2þ pericytes in wound
areas in MFG-E8 KO mice was decreased by 50% to 70%,
compared with WT mice (Figure 4A). These results suggest
that MFG-E8 enhances angiogenesis in granulation tissue
during the tissue-formation phase of skin wound healing.
Fibroblasts are attracted from the edges of wounds or
from bone marrow during the tissue-formation phase of
wound healing.31 Activation of ﬁbroblasts causes differen-
tiation into myoﬁbroblasts that express aSMA.32,33
Furthermore, it has also been reported that pericytes in
skin and kidney can differentiate into myoﬁbroblasts.34,35
Myoﬁbroblasts facilitate wound healing by remodeling
extracellular matrix, secreting growth factors, and causing1986wound contracture. The amount of aSMAþ pericytes or
myoﬁbroblasts in the granulation tissue in MFG-E8 KO
mice was reduced by approximately 80%, compared with
WT mice (Figure 4B), suggesting that MFG-E8 might be
involved in the differentiation of pericytes into myoﬁbro-
blasts and/or in the migration of myoﬁbroblast precursors.
During the tissue-formation phase of wound healing,
recruited macrophages secrete growth factors (including
VEGF and PDGF) and induce angiogenesis.1,2 We therefore
quantiﬁed macrophages in granulation tissue in MFG-E8
WT and KO mice. Numbers of CD68þ macrophages in
granulation tissue did not differ between MFG-E8 WT and
KO mice (Figure 4C), suggesting that the delay of wound
healing in MFG-E8 KO mice cannot be attributed to
reduced macrophage inﬁltration.
Inhibition of the Formation of Capillary-Like Structures
Composed of Pericyte-Like Cells and Endothelial Cells
by MFG-E8 siRNAs
Seeking a direct link of MFG-E8 to angiogenesis, we
examined the effects of MFG-E8 depletion in a capillary-
like structure formation assay in vitro using HUVECs and
murine C3H 10T1/2 cells as surrogates for pericytes andajp.amjpathol.org - The American Journal of Pathology
Figure 5 MFG-E8 siRNAs inhibit formation of capillary-like structures of pericyte-like cells and endothelial cells. A: Inhibition of MFG-E8 mRNA expression
after transfection of ECs (HUVEC) or pericyte-like cells (10T1/2) with siRNAs, determined using RT-qPCR. BeD: Inhibition of the formation of capillary-like
structures by ECs (HUVEC) (B), pericyte-like cells (10T1/2) (C), and both ECs and pericyte-like cells (D) using MFG-E8 siRNAs is shown in images. Quantiﬁ-
cation of total relative length of capillary-like structures of ECs and/or pericyte-like cells in six random microscopic ﬁelds in three independent experiments
was performed using ImageJ software. Data are expressed as means  SEM, normalized to networks formed by control siRNA-treated cells, from three in-
dependent experiments. *P < 0.05, **P < 0.01 versus control, Student’s t-test. Original magniﬁcation, 40. Ctl, control.
MFG-E8 and Cutaneous Wound Healingpericyte precursors. HUVECs and pericyte-like cells (10T1/
2) were depleted of MFG-E8 with siRNA and cocultured on
Matrigel. In these experiments, we achieved a marked
reduction of MFG-E8 mRNA and protein levels in both
HUVECs and 10T1/2 cells (Figure 5A and Supplemental
Figure S2). Depletion of MFG-E8 in ECs (HUVECs)
reduced formation of capillary-like structures (Figure 5B).
Depletion of MFG-E8 in pericyte-like cells (10T1/2) also
reduced formation of capillary-like structures (Figure 5C).
Furthermore, depletion of MFG-E8 in both ECs and
pericyte-like cells reduced formation of capillary-like
structures by approximately 20% (Figure 5D). These re-
sults suggest that MFG-E8 derived from ECs, pericytes, or
both cell types might regulate angiogenesis.Accumulation and Distribution of MFG-E8 in Close
Proximity to Pericytes in Human Granulation Tissue
Fibrous granulation tissue is a characteristic of nonhealing
wounds. Fibrous granulation tissue from intractable ulcers
contained smaller numbers of blood vessels, compared with
better vascularized normal granulation tissue (Figure 6, A
and B). We examined the localization and amount of MFG-
E8 in human normal and ﬁbrous granulation tissue. In both
normal and ﬁbrous granulation tissue, MFG-E8 localized
around CD31þ ECs and colocalized with aSMAþ pericytes
(Figure 6C), as we had demonstrated in granulation tissue inThe American Journal of Pathology - ajp.amjpathol.orgmurine skin wounds (Figure 2, E and F). Lesser amounts of
MFG-E8 were present in ﬁbrous granulation tissue with
scant vessels, compared with normal granulation tissue,
which contained many blood vessels (Figure 6D). These
results suggest that MFG-E8 might regulate angiogenesis in
human as well as in mouse granulation tissue.
Discussion
Using immunoﬂuorescence, we determined that MFG-E8
accumulated around CD31þ ECs and colocalized with
aSMAþ or PDGFRbþ pericytes in human and murine
dermis. These results are consistent with our previous ﬁnd-
ings, that MFG-E8 colocalized with PDGFRbþ pericytes in
B16 melanoma tumors.23 Because MFG-E8 is a secreted
protein, this result does not prove that MFG-E8 originates in
dermal pericytes. However, we had previously demonstrated
(using ﬂuorescence-activated cell sorting and qPCR) that
pericytes in melanoma tissues produce MFG-E8,23 which
suggests that pericytes are likely to be a major source of
MFG-E8 in the dermis in normal murine and human skin.
In the process of wound healing, tissue formation occurs
from 2 to 10 days after wounding and is characterized by
epithelialization, the formation of granulation tissue and
new blood vessels, and the migration of macrophages and
ﬁbroblasts. MFG-E8 protein and mRNA levels were
increased in granulation tissue in wound areas from 4 to 141987
Figure 6 Accumulation and distribution of
MFG-E8 in close proximity to pericytes in human
granulation tissue. A: Clinical appearance of
normal granulation tissue in decubitus ulcer and
ﬁbrous granulation tissue in intractable decubitus
ulcer. B: Histological appearance of normal and
ﬁbrous human granulation tissue. H&E stain. C:
Localization of MFG-E8 in relationship to endo-
thelial cells (CD31þ) or pericytes (aSMAþ) in
human granulation tissue. D: Quantiﬁcation of the
extent of MFG-E8 expression, CD31þ ECs, and
aSMAþ pericytes in normal and ﬁbrous granulation
tissue in eight random microscopic ﬁelds in three
independent experiments was performed using
ImageJ software. Positive area in normal granu-
lation tissue was assigned a value of 1. Data are
expressed as means  SEM. n Z 3. **P < 0.01,
Student’s t-test. Scale bar Z 20 mm.
Uchiyama et aldays after wounding. In addition, in both BALB/c and
C57BL/6 mice, wound healing was signiﬁcantly delayed in
MFG-E8 KO mice. Addition of rMFG-E8 into wounds
reversed the inhibition of wound healing caused by MFG-E8
knockdown. These results suggest that MFG-E8 might pro-
mote wound healing during the tissue-formation phase.
Wound healing is delayed in MFG-E8 KO mice of both
C57BL andBALB/c backgrounds during the tissue-formation
phase. However, wounds in KO mice eventually heal1988completely, and by the same time points as in the WT mice.
The explanations for this observation are unknown. We
measured wound size every other day, not every day, and so
we might not detect small differences (<2 days) in wound
closure time between WT and KO mice.
MFG-E8 was diffusely distributed in granulation tissue,
with accumulations around CD31þ ECs and more extensive
association with aSMAþ pericytes or myoﬁbroblasts. CD31þ
EC numbers were reduced in granulation tissue in MFG-E8ajp.amjpathol.org - The American Journal of Pathology
MFG-E8 and Cutaneous Wound HealingKO mice, and NG2þ pericyte numbers in MFG-E8 KO mice
were also reduced. These results are consistent with our pre-
vious ﬁndings of reduced numbers of PDGFRbþ pericytes and
CD31þ ECs in melanoma tumors from MFG-E8 KO mice.23
The present results suggest that MFG-E8 might promote
wound healing during the tissue-formation phase by
enhancing angiogenesis in granulation tissue.
Consistent with this hypothesis, depletion of MFG-E8 in
ECs and pericyte-like cells using siRNA attenuated the for-
mation of capillary-like structures in vitro. We had previ-
ously determined that MFG-E8 enhances PDGF-stimulated
migration of pericytes-like 10T1/2 cells via enhancement of
PDGF:PDGFRb signaling-mediated integrin-growth factor
receptor crosstalk,24 and others have demonstrated that ECs
require MFG-E8 for VEGF-induced proliferation and sur-
vival.20 We speculate, therefore, that MFG-E8 is produced
primarily by pericytes or myoﬁbroblasts and acts on pericytes
and ECs by potentiating the stimulatory effects of PDGF and
VEGF, respectively, thus leading to enhanced angiogenesis.
Myoﬁbroblasts play important roles in wound healing
through matrix remodeling, growth factor secretion, and
wound contraction.36 Recently, both ﬁbroblasts and pericytes
have been reported to be myoﬁbroblast precursors.24,35 In
addition, it has been reported that pericytes and ﬁbroblasts are
derived from mesenchymal stem cells, and that they can
transdifferentiate into each other.4,37 In the present study,
MFG-E8 was associated with aSMAþ pericytes or myoﬁ-
broblasts in granulation tissue, and the number of aSMAþ
pericytes or myoﬁbroblasts in granulation tissue in MFG-E8
KO mice was signiﬁcantly inhibited, compared with WT
mice. Perhaps MFG-E8 is involved in the differentiation of
precursors into myoﬁbroblast or in the migration of myoﬁ-
broblasts precursors.
We had previously demonstrated that depletion of
MFG-E8 in pericyte-like cells (10T1/2) did not alter TGF-
b-induced differentiation into myoﬁbroblasts.23 In those
analyses, however, PDGF-dependent pericyte-like cell (10T1/
2) migration was inhibited by the depletion of MFG-E8 using
siRNA.23 Furthermore, it has been reported that blocking
PDGFRb signaling inhibited proliferation and migration of
ﬁbroblasts and pericytes, but did not prevent the differentiation
into myoﬁbroblasts in vitro.3 Taken together, these results
suggest that MFG-E8 might regulate migration of myoﬁbro-
blast precursors, including ﬁbroblasts and pericytes into
wounds, but not differentiation into myoﬁbroblasts.
Myoﬁbroblasts are responsible for wound contracture. In
the present study, the numbers of myoﬁbroblasts in wound
areas in MFG-E8 KO mice were reduced, but wound closure
time did not differ markedly between MFG-E8 WT and KO
mice. Recently, it has been reported that tissue tension
generated by myoﬁbroblasts pulled vessels into granulation
tissue from pre-existing vascular beds as vascular loops with
functional circulation, suggesting that contractile forces of
myoﬁbroblasts might contribute to angiogenesis.38 This in
turn suggests that reductions in myoﬁbroblasts in wound
areas in MFG-E8 KO mice might be associated withThe American Journal of Pathology - ajp.amjpathol.orgdecreased vascularity, highlighting another mechanism by
which MFG-E8 may regulate angiogenesis.
Our present ﬁndings implicate MFG-E8 in skin wound
healing. At steady state, MFG-E8 appears to be mainly
produced by ECs and pericytes, and MFG-E8 localizes
around blood vessels. In response to injury or wounding,
MFG-E8 accumulation and expression is enhanced in gran-
ulation tissue and around blood vessels. MFG-E8 may
enhance angiogenesis in granulation tissue by acting directly
on ECs or pericytes. MFG-E8 might also enhance migration
of pericytes or ﬁbroblasts into wound areas, leading to in-
creases in myoﬁbroblasts. In aggregate, these activities of
MFG-E8 promote skin wound healing. MFG-E8 may also
regulate pericyte or ﬁbroblast migration via enhancement of
PDGFRb signaling. Finally, we demonstrated that MFG-E8
localized around CD31þ ECs and associated with aSMAþ
pericytes in human granulation tissue, and that MFG-E8
expression in ﬁbrous granulation tissue with scant blood
vessels was less than that in normal granulation tissue with
abundant vessels, suggesting that MFG-E8 might regulate
angiogenesis in human granulation tissue. Additional studies
are needed to elucidate the roles of MFG-E8 in the regulation
of wound healing in humans, including examination of
angiogenesis, contraction, and differentiation of ﬁbroblasts.
It may be that abnormalities in MFG-E8 production or
function contribute to the intractable wound healing that
causes considerable morbidity in patients with diabetic or
decubitus ulcers. MFG-E8 may have utility as a therapeutic
in these difﬁcult cases.
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